+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In vitro paraoxon (E 600) exposure: No activating effect on human blood coagulation



In vitro paraoxon (E 600) exposure: No activating effect on human blood coagulation



Toxicology 119(2): 167-173



The in vitro effects of the organophosphorus compound (OPC) paraoxon (POX) on human blood coagulation were assessed by fibrin monomer (FM) concentration measurements and thrombelastographic (TEG) determinations. Increasing doses of POX dissolved in alcohol (POX + ALO) or alcohol (ALO) only in corresponding quantities were added to blood drawn from six human volunteers. In both series (POX + ALO and ALO-only) FM concentrations increased in comparison to the baseline levels. No statistically significant differences exist, however, between FM measurements performed on blood with POX + ALO and those performed on blood with ALO-only. No coagulation-activating effect of POX in vitro was demonstrable; the changes seen in vitro are due to the ALO used as a vehicle. The thrombelastographic parameters showed several changes in the POX + ALO series as dosage increased. At high POX levels, reaction time r and clot formation time k became longer than in the baseline measurements, the clot formation rate alpha and the maximum amplitude MA were reduced. The TEG changes indicate a hypocoagulable state, probably due to the POX effect on platelet function and/or inhibition of clotting factors (serine proteases).

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008838786

Download citation: RISBibTeXText

PMID: 9128188

DOI: 10.1016/s0300-483x(97)03622-6


Related references

In vitro paraoxon exposure Soluble fibrinmonomer measurements studies on human blood. Naunyn-Schmiedeberg's Archives of Pharmacology 354(4 Suppl. 1): R20, 1996

In vitro paraoxon exposure No activating effect on human blood coagulation. Toxicology. 119(2): 167-173, 1997

Oxidative stress responses to carboxylic acid functionalized single wall carbon nanotubes on the human intestinal cell line Caco-2. Toxicology in Vitro 26(5): 672-677, 2012

Effect of activated protein C in second intention healing of equine distal limb wounds: a preliminary study. Australian Veterinary Journal 93(10): 361-366, 2015

Paraoxon does not inhibit beta-lactamase. Naunyn-Schmiedeberg's Archives of Pharmacology 357(4 Suppl.): R173, 1998

Intravenous pantoprazole: a new tool for acutely ill patients who require acid suppression. Canadian Journal of Gastroenterology 14 Suppl D: 11d-20d, 2000

Intravenous paracetamol pharmacokinetics in term and preterm neonates. European Journal of Clinical Pharmacology 60(3): 191-197, 2004

Effect of beta particle irradiation upon experimentally induced chronic inflammatory arthritis. Annals of the Rheumatic Diseases 29(2): 202-203, 1970

The effect of catecholamines on the delay of the restorative response after subtotal hepatectomy. British Journal of Experimental Pathology 48(3): 305-308, 1967

Possible effect of hydrocortisone on bilirubin excretion by the liver. New England Journal of Medicine 257(2): 62-65, 1957

Blood transfusion and blood coagulation. Bibliotheca Haematologica 6: 93, 1957

Studies in Blood Coagulation Physiology Relative to the "chyle Jet Effect". Das Deutsche Gesundheitswesen 20: 63-65, 1965

Effect of hemodialysis, coronary artery disease and diabetes on cardiac troponin T: a prospective survey over one year. Open Cardiovascular Medicine Journal 3: 69-77, 2009

Electron microscopic findings in blood coagulation. II. Nature of atypical plasma coagulation occurring in the vicinity of thrombocytes in fresh human thrombocytecitrate plasma. Arztliche Forschung 11(3): I/127-I/133, 1957